Cargando…
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)
Mutations in the SNCA (α-synuclein, PARK1) gene significantly contribute to Parkinson’s disease (PD) and SNCA inclusions are strongly associated with PD. Fibroblasts from a 51-year-old female patient with disease onset at 39 years, carrying the A53T SNCA mutation (LCSBi003, ND40996), and fibroblasts...
Autores principales: | Novak, Gabriela, Finkbeiner, Steven, Skibinski, Gaia, Skupin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124237/ https://www.ncbi.nlm.nih.gov/pubmed/34826737 http://dx.doi.org/10.1016/j.scr.2021.102600 |
Ejemplares similares
-
SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress
por: Byers, Blake, et al.
Publicado: (2011) -
Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy
por: Mohamed, Nguyen-Vi, et al.
Publicado: (2021) -
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022) -
Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s disease
por: Zafar, Faria, et al.
Publicado: (2018) -
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)